Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 2
1982 1
1985 3
1987 1
1988 1
1989 1
1990 7
1991 7
1992 4
1993 10
1994 8
1995 12
1996 23
1997 24
1998 21
1999 26
2000 21
2001 33
2002 37
2003 44
2004 44
2005 57
2006 68
2007 66
2008 86
2009 109
2010 114
2011 140
2012 152
2013 200
2014 253
2015 293
2016 299
2017 356
2018 373
2019 420
2020 519
2021 588
2022 519
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

4,486 results
Results by year
Filters applied: . Clear all
Page 1
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
Falsey AR, Frenck RW Jr, Walsh EE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Bailey R, Swanson KA, Xu X, Koury K, Kalina W, Cooper D, Zou J, Xie X, Xia H, Türeci Ö, Lagkadinou E, Tompkins KR, Shi PY, Jansen KU, Şahin U, Dormitzer PR, Gruber WC. Falsey AR, et al. Among authors: xia h. N Engl J Med. 2021 Oct 21;385(17):1627-1629. doi: 10.1056/NEJMc2113468. Epub 2021 Sep 15. N Engl J Med. 2021. PMID: 34525276 Free PMC article. Clinical Trial. No abstract available.
Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines.
Liu J, Wang J, Xu J, Xia H, Wang Y, Zhang C, Chen W, Zhang H, Liu Q, Zhu R, Shi Y, Shen Z, Xing Z, Gao W, Zhou L, Shao J, Shi J, Yang X, Deng Y, Wu L, Lin Q, Zheng C, Zhu W, Wang C, Sun YE, Liu Z. Liu J, et al. Among authors: xia h. Cell Discov. 2021 Oct 26;7(1):99. doi: 10.1038/s41421-021-00329-3. Cell Discov. 2021. PMID: 34697287 Free PMC article.
FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations.
Mathieu LN, Larkins E, Akinboro O, Roy P, Amatya AK, Fiero MH, Mishra-Kalyani PS, Helms WS, Myers CE, Skinner AM, Aungst S, Jin R, Zhao H, Xia H, Zirkelbach JF, Bi Y, Li Y, Liu J, Grimstein M, Zhang X, Woods S, Reece K, Abukhdeir AM, Ghosh S, Philip R, Tang S, Goldberg KB, Pazdur R, Beaver JA, Singh H. Mathieu LN, et al. Among authors: xia h. Clin Cancer Res. 2022 Jan 15;28(2):249-254. doi: 10.1158/1078-0432.CCR-21-1566. Epub 2021 Aug 3. Clin Cancer Res. 2022. PMID: 34344795 Review.
The role of 5-HT metabolism in cancer.
Ye D, Xu H, Tang Q, Xia H, Zhang C, Bi F. Ye D, et al. Among authors: xia h. Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188618. doi: 10.1016/j.bbcan.2021.188618. Epub 2021 Aug 21. Biochim Biophys Acta Rev Cancer. 2021. PMID: 34428515 Review.
Releasing Antiaromaticity in Metal-Bridgehead Naphthalene.
Tang C, Zhao Y, Wu J, Chen Z, Liu LL, Tan YZ, Zhu J, Xia H. Tang C, et al. Among authors: xia h. J Am Chem Soc. 2021 Sep 29;143(38):15587-15592. doi: 10.1021/jacs.1c08106. Epub 2021 Sep 17. J Am Chem Soc. 2021. PMID: 34533932
Photon-counting distributed free-space spectroscopy.
Yu S, Zhang Z, Xia H, Dou X, Wu T, Hu Y, Li M, Shangguan M, Wei T, Zhao L, Wang L, Jiang P, Zhang C, You L, Tao L, Qiu J. Yu S, et al. Among authors: xia h. Light Sci Appl. 2021 Oct 12;10(1):212. doi: 10.1038/s41377-021-00650-2. Light Sci Appl. 2021. PMID: 34642297 Free PMC article.
4,486 results